Visual Pathway Measures are Associated with Neuropsychological Function in Multiple Sclerosis

References

• Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD, Prince JL, Pham D, Roy S, Zijl P, et al. Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol. 2015;78(5):801–13. doi:10.1002/ana.24487.
   PubMed Web of Science ®Google Scholar
• Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler J. 2011;17(12):1449–63. doi:10.1177/1352458511418630.
   PubMed Web of Science ®Google Scholar
• Talman LS, Bisker ER, Sackel DJ, Long DA Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in MS. Ann Neurol. 2010;67(6):749–60.
   PubMed Web of Science ®Google Scholar
• Walter SD, Ishikawa H, Galetta KM, Sakai RE, Henderson SB, Wilson JA, Maguire MG, Galetta SL, Frohman E, Calabresi PA, et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology. 2012;119(6):1250–57. doi:10.1016/j.ophtha.2011.11.032.
   PubMed Web of Science ®Google Scholar
• Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7(12):1139–51. doi:10.1016/S1474-4422(08)70259-X.
   PubMed Web of Science ®Google Scholar
• Dusankova JB, Kalincik T, Havrdova T, Benedict RH. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Clin Neuropsychol. 2012;26(7):1186–200. doi:10.1080/13854046.2012.725101.
   PubMed Web of Science ®Google Scholar
• Ratchford JN, Saidha S, Sotirchos ES, Oh JA, Seigo MA, Eckstein C, Durbin MK, Oakley JD, Meyer SA, Conger A, et al. Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology. 2013;80(1):47–54. doi:10.1212/WNL.0b013e31827b1a1c.
   PubMed Web of Science ®Google Scholar
• El Ayoubi NK, Ghassan S, Said M, Allam J, Darwish H, Khoury SJ. Retinal measures correlated with cognitive and physical disability in early multiple sclerosis. J Neurol. 2016;263(11):2287–95. doi:10.1007/s00415-016-8271-4.
   PubMed Web of Science ®Google Scholar
• Ashtari F, Emami P, Akbari M. Association between retinal nerve fiber layer thickness and magnetic resonance imaging findings and intelligence in patients with multiple sclerosis. Adv Biomed Res. 2015;4:223. doi:10.4103/2277-9175.166646.
   PubMedGoogle Scholar
• Toledo J, Sepulcre J, Salinas-Alaman A, Garcia-Layana A, Murie-Fernandez M, Bejarano B, Villoslada P. Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis. Mult Scler J. 2008;14(7):906–12. doi:10.1177/1352458508090221.
   PubMed Web of Science ®Google Scholar
• Feaster HT, Bruce JM. Visual acuity is associated with performance on visual and non-visual neuropsychological tests in multiple sclerosis. Clin Neuropsychol. 2011;25(4):640–51. doi:10.1080/13854046.2011.565075.
   PubMed Web of Science ®Google Scholar
• Wieder L, Gade G, Pech LM, Zimmermann H, Wernecke KD, Dörr JM, Bellmann-Strobl J, Paul F, Brandt AU. Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study. BMC Neurol. 2013;13:167. doi:10.1186/1471-2377-13-167.
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302. doi:10.1002/ana.22366.
   PubMed Web of Science ®Google Scholar
• Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørenson PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof B, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83:278–86. doi:10.1212/WNL.0000000000000560.
   PubMed Web of Science ®Google Scholar
• Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, Oakley JD, Durbin MK, Meyer SA, Balcer LJ, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011;134(pt 2):518–33. doi:10.1093/brain/awq346.
   PubMed Web of Science ®Google Scholar
• Schippling S, Balk LJ, Costello F, Albrecht P, Balcer L, Calabresi PA, Frederiksen JL, Frohman E, Green AJ, Klistorner A, et al. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler. 2015;21(2):163–70. doi:10.1177/1352458514538110.
   PubMed Web of Science ®Google Scholar
• Tewarie P, Balk L, Costello F, Green A, Martin R,Schippling S, Petzold A. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One. 2012;7(4):e34823. doi:10.1371/journal.pone.0034823.
   PubMed Web of Science ®Google Scholar
• Bhargava P, Lang A, Al-Louzi O, Carass A, Calabresi PA, Saidha S. Applying an open-source segmentation algorithm to different OCT devices in multiple sclerosis patients and healthy controls: implications for clinical trials. Mult Scler Int J. 2015;2015:136295.
   PubMedGoogle Scholar
• Smith A. Symbol digit modalities test manual. Los Angeles (CA): Western Psychological Services; 1973.
   Google Scholar
• Fischer JS, Jak AJ, Kniker JE, Rudick RA, Cutter G. Multiple sclerosis functional composite: administration and scoring manual. Denver (CO): National Multiple Sclerosis Society; 2001.
   Google Scholar
• Benedict RHB. Brief visuospatial memory test – revised, professional manual. Lutz (FL): PAR; 1997.
   Google Scholar
• Ross T, Calhoun E, Cox T, Wenner C, Kono W, Pleasant M. The reliability and validity of qualitative scores for the controlled oral word association test. Arch Clin Neuropsychol. 2007;22(4):475–88. doi:10.1016/j.acn.2007.01.026.
   PubMed Web of Science ®Google Scholar
• Benton A. Benton judgment of line orientation form V. Richmond (CA): Neuropsychological Assessments Inc; 1994.
   Google Scholar
• Delis D, Kaplan E, Kramer J. Delis-Kaplan Executive Function System (D-KEFS). San Antonio (TX): Pearson Clinical Psychology; 2001.
   Google Scholar
• Bender R, Lange S. Adjusting for multiple testing–when and how? J Clin Epidem. 2001;54(4):343–49. doi:10.1016/S0895-4356(00)00314-0.
   PubMed Web of Science ®Google Scholar
• Benedict RHB, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N, Weinstock-Guttman B. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006;12(4):549–58. doi:10.1017/S1355617706060723.
   PubMed Web of Science ®Google Scholar
• Drake AS, Weinstock-Guttman B, Morrow SA, Hojnacki D, Munschauer FE, Benedict RH. Psychometrics and normative data for the multiple sclerosis functional composite: replacing the PASAT with the symbol digit modalities test. Mult Scler. 2010;16(2):228–37. doi:10.1177/1352458509354552.
   PubMed Web of Science ®Google Scholar
• Balcer LJ, Frohman E. Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Neurology. 2010;74(Suppl Issue 17, Supplement 3):S16–S23. doi:10.1212/WNL.0b013e3181dbb664.
   PubMed Web of Science ®Google Scholar
• Hainline C, Rizzo JR, Hudson TE, Dai W, Berkemeier J, Raynowska J, Nolan RC, Hasanaj L, Selesnick I, Frohman TC, et al. Capturing saccades in multiple sclerosis with a digitized test of rapid number naming. J Neurol. 2017;264(5):989–98. doi:10.1007/s00415-017-8484-1.
   PubMed Web of Science ®Google Scholar
• Rizzo R, Anderson SW, Dawson J, Nawrot M. Vision and cognition in Alzheimer’s disease. Neuropsychologia. 2000;38(8):1157–69. doi:10.1016/S0028-3932(00)00023-3.
   PubMed Web of Science ®Google Scholar
• Crucian GP, Okun MS. Visual-spatial ability in Parkinson’s disease. Front Biosci. 2003;8:s992–997. doi:10.2741/1171.
   PubMed Web of Science ®Google Scholar
• Balcer LJ, Galetta SL, Calabresi PA, Confavreux C, Giovanonni G, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Miller DH, et al. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology. 2007;68(16):1299–304. doi:10.1212/01.wnl.0000259521.14704.a8.
   PubMed Web of Science ®Google Scholar
• Balcer LJ, Galetta SL, Polman CH, Eggenberger E, Calabresi PA, Zhang A, Scanlon JV, Hyde R. Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS. J Neurol Sci. 2012;318(1–2):119–24. doi:10.1016/j.jns.2012.03.009.
   PubMed Web of Science ®Google Scholar
• Bever CT Jr., Grattan HS, Panitch HS, Johnson KP. The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study. Mult Scler. 1995;1(3):165–69. doi:10.1177/135245859500100306.
   PubMedGoogle Scholar
• Freeman JA, Hobart JC, Langdon DW, Thompson AJ. Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis. J Neurol Neurosurg Psych. 2000;68:150–56. doi:10.1136/jnnp.68.2.150.
   PubMed Web of Science ®Google Scholar
• Saidha S, Sotrichos ES, Oh J, Syc SB, Seigo MA, Shiee N, Eckstein C, Durbin MK, Oakley JD, Meyer SA, et al. Retinal axonal and neuronal measures in multiple sclerosis reflect global CNS pathology. JAMA Neurol. 2013;70(1):34–43. doi:10.1001/jamaneurol.2013.573.
   PubMed Web of Science ®Google Scholar
• Stelmann JP, Cetin H, Young KL, Hodeck S, Pöttgen J, Bittersohl D, Hassenstein A, Oberwahrenbrock T, Heesen C, Siemonsen S. Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing–remitting MS. Brain Behav. 2016;7(2):e00614. doi:10.1002/brb3.614.
   PubMed Web of Science ®Google Scholar
• Pointer JS. Habitual vs optimal distance visual acuity. Ophthalmic Physiol Opt. 2008;28:457–66. doi:10.1111/j.1475-1313.2008.00584.x.
   PubMed Web of Science ®Google Scholar
• Benedict RH, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J, Chelune GJ, Fisk JD, Langdon DW, Caruso L, et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol. 2002;16:381–97. doi:10.1076/clin.16.3.381.13859.
   PubMed Web of Science ®Google Scholar